Morgan Stanley’s Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share ROSS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-66
Closed -$4 8040
2023
Q4
$4 Buy
66
+33
+100% +$2 ﹤0.01% 7802
2023
Q3
$4 Hold
33
﹤0.01% 7586
2023
Q2
$6 Hold
33
﹤0.01% 7620
2023
Q1
$9 Buy
+33
New +$7 ﹤0.01% 7676

Other funds holding ROSS.WS

Morgan Stanley's ROSS.WS Position: Q1 2024 in Review

Morgan Stanley sold out of Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (ROSS.WS) in Q1 2024, closing a stake of 66 shares — an estimated $4 sold.

Morgan Stanley first reported a position in ROSS.WS in Q1 2023 and held it in 4 quarters. The position peaked at $9 in Q1 2023. 6 funds tracked by Wall St. Rank hold ROSS.WS as of Q1 2024.

  • Morgan Stanley reported no remaining Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 66 Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2024, an estimated $4.
  • Morgan Stanley first reported a position in Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2023 and held it in 4 quarters.
  • Morgan Stanley's Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $9 in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.